The Food and Drug Administration is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to ...
The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...
The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people ...
NMRA-898 is structurally distinct from NMRA-861 and is the second M4 PAM in Neumora's M4 franchise; both programs have potential best-in-class pharmacology No convulsions observed in pre-clinical stud ...
NMRA-898 is structurally distinct from NMRA-861 and is the second M4 PAM in Neumora’s M4 franchise; both programs have potential best-in-class ...
NMRA-215 demonstrated class-leading weight loss of up to 19% as a monotherapy with semaglutide-like induction NMRA-215 demonstrated best-in-class ...
ChemDiv, a global provider of integrated drug discovery solutions, today announced that it will continue providing chemistry, computational, and clinical pharmacology support to Clywedog Therapeutics ...
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have published a ...
In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.
Scientists continue to explore ways we can live longer and ensure those lives are healthier. A new discovery of note in this field comes from experiments in fission yeast (an organism often used for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback